Geneva has been officially confirmed as the host city for the SLAS Europe Conference and Exhibition for three upcoming editions, 2028, 2030, and 2032, highlighting Switzerland’s growing role as a hub for innovation in life sciences and technology.
The Society for Laboratory Automation and Screening (SLAS) has officially selected Geneva, Switzerland, as the host city for three future editions of its flagship SLAS Europe Conference and Exhibition, to be held in 2028, 2030, and 2032. All three events will take place at Palexpo, Geneva’s largest exhibition and conference centre, ideally located near the international airport.
This decision marks a major success for Geneva’s meetings industry and highlights the city’s growing appeal as a hub for innovation at the intersection of life sciences and technology. The Geneva Convention Bureau played a key role in supporting SLAS’s decision, coordinating efforts with local partners to bring the conference to Switzerland for the first time.
“SLAS Europe is not just a regional meeting, it’s a global event for advancing science and automation that is anchored in excellence and collaboration,” said SLAS CEO Vicki Loise, CAE, CMP. “With Geneva being a home to so many global scientific and pharma organisations, biotech companies, world class universities and research institutions, it is a natural convening point for our European conference that connects science, technology, and people.”
Founded in 2010, SLAS (Society for Laboratory Automation and Screening) is a global, non-profit professional community of more than 20,000 scientists, engineers, researchers, academics, and business leaders from across the life sciences, pharmaceutical, biotech, and technology industries. SLAS’s mission is to foster knowledge sharing and collaboration that unites scientists, educators and industry professionals to co-create solutions for a healthier world.
Through its international conferences, open-access scientific journals, and educational programs, SLAS provides a platform for knowledge exchange, networking, and collaboration. The organisation also supports start-ups and young scientists through innovation competitions, mentoring initiatives, and technology showcases that bridge academic research and industry application.
“Hosting SLAS Europe underscores Geneva’s ability to attract major international scientific events beyond the traditional medical field,” said Laureline Herde, Business Development Manager at the Geneva Convention Bureau.
“This achievement also reflects a truly national effort, with key representatives from across Switzerland, including academic institutions, innovation clusters, and industry partners, coming together to showcase the strength and diversity of the Swiss life sciences and technology ecosystem. It is a success for Geneva, but also for Switzerland as a whole.”
The SLAS Europe Conference and Exhibition will bring together thousands of delegates, researchers, and companies from around the world to exchange ideas, discover the latest technological advancements, and explore the future of automation and innovation in the life sciences.Amy Wilkinson, CMP, CEM, DES, SLAS Director Global Events & Corporate Partnerships, added, “From a logistics point of view, Geneva is a wonderful place to organize and attend a conference, with its safe, clean, efficient infrastructure and a stunning natural setting that is easy to get to via air or rail – what’s not to like?”
